Skip to content
Peptigraph home

Selank for Depression: What the Evidence Shows

What human and animal studies show about Selank for depression, how strong that evidence is, and what is still unproven.

Medically reviewed by Juan Pablo Frías, MD · · DisclosureTuftsin analogUpdated
Strongest evidence
Animal
Human studies
2
PubMed records, our ledger
Animal studies
5
PubMed records, our ledger
Studies we summarised
1
with an outcome for depression

Evidence for depression

Each row is an outcome related to depression from a published study, strongest design first. Animal and cell results are labelled and are not human results. User reports are not counted as evidence here.

Selank for depression: outcomes in published studies
OutcomeResultStudy typeSource
Depression-like behaviour in WAG/Rij ratsHigh-dose repeated selank (1000-2000 microg/kg) counteracted depression-like behaviour in WAG/Rij rats.Animal · rat and mouse (not a human result)Zhurnal vysshei nervnoi deiatelnosti imeni I P Pavlova 2008, PMID 18661785
Forced swim test in BALB/c miceA single low dose reduced immobility in mice but repeated or higher doses did not.Animal · rat and mouse (not a human result)Zhurnal vysshei nervnoi deiatelnosti imeni I P Pavlova 2008, PMID 18661785

PubMed records for Selank and depression: 2 human, 5 animal (search counts, not studies we reviewed). Grades follow our .

How strong is it?

A human randomized trial outweighs any number of animal studies. Animal and cell results show a mechanism worth testing, not that it works in people.

What depression is

MedlinePlus says major depression symptoms include a depressed mood or a loss of interest and affect daily activities.[2]

Human data: anxiety trials, not depression trials

The depression PubMed query for selank (run 2026-10-02) found 2 human, 5 animal and 0 randomized-trial records among 7 in all.

Calculated from human 2; human only 2; animal 5; rct 0; all 7. Formula: Counts copied from the selank ledger row of the depression goal in goals.json; no arithmetic.

A trial comparing selank (30 patients) with medazepam (32 patients) found similar anxiolytic effects, with antiasthenic and psychostimulant effects reported for selank. It studied anxiety, not depression.[3]

In a cell experiment with blood from patients with depression, selank at 10-7 M completely suppressed IL-6 gene expression in the patients' cells but not in healthy controls.[4]

Animal depression models

In WAG/Rij rats, a strain with depression-like behavior, repeated high doses of selank counteracted forced-swim immobility and reduced sucrose intake.[1]

In BALB/c mice, low single doses reduced forced-swim immobility, but repeated injection or higher doses had no significant effect.[1]

Other peptides people research for depression

All peptides for depression, compared

Common questions

Does Selank help with depression?

The strongest study we summarise for depression is animal evidence, across 1 study with an outcome for depression. That is not proof it works in people.

Is Selank approved for depression?

No. Selank is not FDA approved for any use, including depression.

What is the best peptide for depression?

There is no single answer. Our depression overview compares each candidate by evidence grade and legal status rather than by popularity.

Does selank help depression?

No human trial in depressed patients is cited here. In animal models, single low doses helped mice but repeated or higher doses did not.[1]

Is selank an antidepressant?

The rat paper reports an antidepressant component in selank's activity, in animals only. The human trials cited studied anxiety.[1]

More on Selank

Sources

  1. 1[Effects of heptapeptide selank on genetically-based and situation-provoked symptoms of depression in behavior in WAG/Rij and Wistar rats, and in BALB/c mice].Zhurnal vysshei nervnoi deiatelnosti imeni I P Pavlova · 2008PMID 18661785Accessed 2 Oct 2026
  2. 2Official web pageOfficial web page · web page
  3. 3[Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia].Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · 2008PMID 18454096Accessed 2 Oct 2026
  4. 4[Immunomodulatory effects of selank in patients with anxiety-asthenic disorders].Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · 2008PMID 18577961Accessed 2 Oct 2026

Found an error? Report a correction.